Skip to main content

Table 3 HPV-capsid antibodies in HIV-positive (+) or HIV-negative (-) men with anogenital carcinoma

From: High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study

VLP-type 6 11 16 18 31 cumulative cumulative
       low risk (6, 11) high risk (16, 18, 31)
HIV + (n = 3) 3/3 2/3 3/3 2/3 2/3 3/3 3/3
HIV - (n = 7) 0/7 0/7 1/7 0/7 1/7 0/7 2/7